These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15373325)

  • 1. Third symposium on new aspects of biology and treatment of B chronic lymphocytic leukemia.
    Berrebi A
    Isr Med Assoc J; 2004 Sep; 6(9):573-5. PubMed ID: 15373325
    [No Abstract]   [Full Text] [Related]  

  • 2. From bench to bedside: the Vth Symposium on the Biology and Treatment of Chronic Lymphocytic Leukemia, January 2008, Tel Aviv.
    Berrebi A
    Isr Med Assoc J; 2008 Dec; 10(12):906-8. PubMed ID: 19160955
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy in chronic lymphocytic leukemia.
    Bruserud Ø; McCormack E; Gjertsen BT
    Cancer Immunol Immunother; 2006 Feb; 55(2):185-7. PubMed ID: 16001162
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
    Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
    Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the microenvironment in chronic lymphocytic leukaemia.
    Caligaris-Cappio F
    Br J Haematol; 2003 Nov; 123(3):380-8. PubMed ID: 14616995
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccine- and immune-based therapy in chronic lymphocytic leukemia.
    Le Dieu R; Gribben J
    Semin Oncol; 2006 Apr; 33(2):220-9. PubMed ID: 16616069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in chronic lymphocytic leukemia. International Workshop on chronic Lymphocytic Leukemia.
    Gale RP; Caligaris-Cappio F; Dighiero G; Keating M; Montserrat E; Rai K
    Leukemia; 1994 Sep; 8(9):1610-4. PubMed ID: 7522296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmunity in chronic lymphocytic leukemia: which B lymphocyte is the culprit?
    Lugassy G
    Isr Med Assoc J; 2006 Dec; 8(12):864. PubMed ID: 17214107
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises.
    Bagacean C; Zdrenghea M; Tempescul A; Cristea V; Renaudineau Y
    Immunotherapy; 2016 May; 8(5):569-81. PubMed ID: 27140410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in biology and therapy of chronic lymphocytic leukemia. Preface.
    Montserrat E
    Best Pract Res Clin Haematol; 2010 Mar; 23(1):1-2. PubMed ID: 20620966
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic lymphoproliferative disorders: chronic lymphocytic leukemia and hairy-cell leukemia.
    Keating MJ
    Curr Opin Oncol; 1993 Jan; 5(1):35-41. PubMed ID: 8427892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.
    Winkelstein A; Jordan PS
    Clin Rev Allergy; 1992; 10(1-2):39-58. PubMed ID: 1606523
    [No Abstract]   [Full Text] [Related]  

  • 13. CD40-ligand/interleukin-2 vaccines in chronic lymphocytic leukemia: the impact of vaccine design.
    Rezvani K
    Cytotherapy; 2011 Oct; 13(9):1029-30. PubMed ID: 21916777
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress in novel cellular therapy options for chronic lymphocytic leukemia: the M D Anderson perspective.
    Shah N; Rezvani K; Hosing C; Kebriaei P; Wierda W; Cooper L; Shpall E
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl(Suppl):S18-22. PubMed ID: 25486950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia: biology and current treatment.
    Zent CS; Kay NE
    Curr Oncol Rep; 2007 Sep; 9(5):345-52. PubMed ID: 17706162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairments in immune cell function in B cell chronic lymphocytic leukemia.
    Bartik MM; Welker D; Kay NE
    Semin Oncol; 1998 Feb; 25(1):27-33. PubMed ID: 9482524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.
    Singh N; Frey NV; Grupp SA; Maude SL
    Curr Treat Options Oncol; 2016 Jun; 17(6):28. PubMed ID: 27098534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. II. Studies of immunologic phenotype of peripheral blood and lymph node lymphocytes in patients with chronic lymphocytic leukemia or leukemic forms of lymphoplasmacytoid lymphoma].
    Rupniewska ZM; Rozynkowa D; Antosz H; Kowal M; Wach M; Roliński J
    Acta Haematol Pol; 1992; 23(1):29-41. PubMed ID: 1615749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in CAR T-cell therapy for chronic lymphocytic leukemia.
    Porter DL
    Clin Adv Hematol Oncol; 2018 Feb; 16(2):118-120. PubMed ID: 29741512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic lymphocytic leukemia: biology, disease progression, and current treatment strategies].
    Yano T
    Rinsho Ketsueki; 2017; 58(10):1960-1972. PubMed ID: 28978838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.